Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Dermatologic Therapy
|
October 6, 2018
Estimated cost efficacy of U.S. Food and Drug Administration-approved treatments for acne
Michael Tassavor, Michael J Payette
Journal of the American Academy of Dermatology
|
April 22, 2018
The student is in: Ethical concerns when dermatology patients refuse medical students
Michael Tassavor, Jane M Grant-Kels
Journal of the American Academy of Dermatology
|
January 9, 2018
Lost in translation: Caring for limited English proficiency patients
Michael Tassavor, Amy Y-Y Chen
JAAD Case Reports
|
November 9, 2019
The utility of dupilumab for use in the pediatric population
Aakaash Varma, Michael Tassavor, Jacob Levitt
Cureus
|
July 26, 2021
Dermatology Resident Billing and the Impact of 2021 Evaluation and Management Coding Changes
Michael Tassavor, Aatman Shah, Jonathan Ungar
Cureus
|
March 4, 2021
Purpura Fulminans Following Toxic Epidermal Necrolysis-Like Presentation of Spontaneous Linear IgA Bullous Disease
Michael Tassavor, Bryan Tassavor, Ameen Al Awadhi
Journal of the American Academy of Dermatology
|
July 23, 2021
Flipped classroom curriculum for dermatologic surgery during COVID-19: A prospective cohort study
Michael Tassavor, Aatman Shah, Peter Hashim, et al.
Dermatology Online Journal
|
August 13, 2021
The various treatment modalities of dermatofibrosarcoma protuberans
Aatman Shah, Michael Tassavor, Sayesha Sharma, et al.
Anticancer Research
|
September 29, 2023
The Integrated i31-GEP Test Outperforms the MSKCC Nomogram at Predicting SLN Status in Melanoma Patients
Michael Tassavor, Brian J Martin, Alex M Glazer
Journal of the American Academy of Dermatology
|
July 21, 2024
Improving melanoma reporting: The Ohio Model
Matthew DaCunha, Michael Tassavor, Madalyn Bland South, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Dermatologic Therapy
|
October 6, 2018
Estimated cost efficacy of U.S. Food and Drug Administration-approved treatments for acne
Michael Tassavor, Michael J Payette
Journal of the American Academy of Dermatology
|
April 22, 2018
The student is in: Ethical concerns when dermatology patients refuse medical students
Michael Tassavor, Jane M Grant-Kels
Journal of the American Academy of Dermatology
|
January 9, 2018
Lost in translation: Caring for limited English proficiency patients
Michael Tassavor, Amy Y-Y Chen
JAAD Case Reports
|
November 9, 2019
The utility of dupilumab for use in the pediatric population
Aakaash Varma, Michael Tassavor, Jacob Levitt
Cureus
|
July 26, 2021
Dermatology Resident Billing and the Impact of 2021 Evaluation and Management Coding Changes
Michael Tassavor, Aatman Shah, Jonathan Ungar
Cureus
|
March 4, 2021
Purpura Fulminans Following Toxic Epidermal Necrolysis-Like Presentation of Spontaneous Linear IgA Bullous Disease
Michael Tassavor, Bryan Tassavor, Ameen Al Awadhi
Journal of the American Academy of Dermatology
|
July 23, 2021
Flipped classroom curriculum for dermatologic surgery during COVID-19: A prospective cohort study
Michael Tassavor, Aatman Shah, Peter Hashim, et al.
Dermatology Online Journal
|
August 13, 2021
The various treatment modalities of dermatofibrosarcoma protuberans
Aatman Shah, Michael Tassavor, Sayesha Sharma, et al.
Anticancer Research
|
September 29, 2023
The Integrated i31-GEP Test Outperforms the MSKCC Nomogram at Predicting SLN Status in Melanoma Patients
Michael Tassavor, Brian J Martin, Alex M Glazer
Journal of the American Academy of Dermatology
|
July 21, 2024
Improving melanoma reporting: The Ohio Model
Matthew DaCunha, Michael Tassavor, Madalyn Bland South, et al.
Page
of 2